NEW YORK (360Dx) – Qiagen said after the close of the market Thursday that its QuantiFeron-TB Gold test for latent tuberculosis has been selected by the Republic of Korea (South Korea) Armed Forces to screen more than 340,000 recruits in 2017.
...and receive Daily News bulletins.
Already have an account?Login Now.
This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.
This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.